CIPLA's weekly performance was modest, with a 0.5% return, outperforming SUNPHARMA but underperforming DIVISLAB. The stock's volatility was relatively low at 17.34%, compared to its peers, indicating a relatively stable week. However, the Sharpe Ratio of 0.12 suggests that the return was not particularly impressive given the level of risk taken. Overall, CIPLA's performance was middling, with a moderate level of risk.

[Volatility: 17.34%]